Delivery Order SPE2DB20D3103-SPE2DB25FN8G8
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order (Contract #SPE2DB20D1100 | SPE2DB24FD9D4) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 5 mg Mitomycin vials. The award is valued at $2,977.68 and has a firm-fixed price. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Mitomycin 5 mg vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,818.90 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,732,286 units of Cyclophosphamide 2 GM vials, a chemotherapy drug. The $70,284.14 firm-fixed-price contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,942.61 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,235,008 vials of the drug Dactinomycin 500 mcg. The contract has a period of performance ending on May 14, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,282.88 firm fixed-price contract is for the delivery of various pharmaceutical and medical supplies to support military healthcare programs. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,809.27, is for the delivery of 4,567,953,384 units of the medication Mycophenolate 500 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $4,617.02 and a completion date of February 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $928,594.82, is for the provision of a variety of pharmaceutical products and medical supplies to support the Department of Defense's healthcare programs and facilities worldwide. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,597.28 firm-fixed-price contract is for the delivery of pharmaceutical products and medical supplies to support military and federal healthcare programs. The contract has a performance period through May 2025 and is not set aside for any special business category. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.28, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract has a firm fixed price pricing type and a completion date of February 24, 2025. This delivery order is part of a larger...